Immutep
IMMP
$2.01
Share price
-5.63%
Change (1 day)
-32.32%
Change (1 year)
Categories
Revenue for Immutep (IMMP)
Revenue in 2017 (TTM): -$0.01 M
According to Immutep's latest financial reports the company's current revenue (TTM) is -$0.01 M. In 2022 the company made a revenue of $0.11 M an increase over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Immutep from 2008 to 2017
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 | $0.11 M | INF% |
| 2021 | N/A | -100% |
| 2020 | $5.14 M | 5140.34% |
| 2019 | $0.09 M | -94.96% |
| 2018 | $1.94 M | INF% |
| 2017 | N/A | -100% |
| 2016 | $0.13 M | INF% |
| 2015 | N/A | NAN% |
| 2014 | N/A | NAN% |
| 2013 | N/A | -100% |
| 2012 | $1.55 M | INF% |
| 2011 | N/A | -100% |
| 2010 | $0.44 M | INF% |
| 2009 | N/A | NAN% |
| 2008 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $4.44 B | -1,599,640,387.77% | 🇺🇸 USA |
 FibroGen FGEN | $0.11 B | -41,751,538.85% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | $6.36 M | -2,290,107.19% | 🇺🇸 USA |